X
X-Therma
X-Therma | Organs on Demand
About X-Therma
X-Therma is a biotechnology company that has developed a biopreservation platform to enhance regenerative medicine. The company's core technology focuses on solutions for the preservation, storage, and transportation of biological materials, such as cells, tissues, and organs, for therapeutic use.
Its main product is a non-toxic cryopreservation solution that aims to prevent ice damage during freezing, which is a significant challenge in the field of biopreservation. This technology is designed to extend the shelf life of biological products, thereby improving the logistics and availability of materials for organ transplantation and other regenerative therapies. The company's business model revolves around providing these advanced preservation solutions to organizations involved in cell and gene therapy, tissue engineering, and organ transplantation. X-Therma operates in the biotechnology and healthcare markets, serving clients in the research, clinical, and commercial sectors of regenerative medicine.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Hercules, United States
- Employees
- 30
- Open positions
- 1
- Dealroom signal
- 66.5/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Hard Tech, ogr torino, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Mar 2024 | $22M | $90M | Lorea AG · Starling Locke Capital | ↗ |
| SERIES A✓Equity / VC | Dec 2021 | $13M | $52M | VU Venture Partners · Cavendish Impact Capital · Zen11 Holdings · 2b AHEAD Ventures | ↗ |
Growth signals
Latest recorded traffic for X-Therma is 2.5K monthly website visits, up 127.3% over the last three months. X-Therma's team declined 3.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A8 investors entered at this stage
Lorea AG
VU Venture Partners
Cavendish Impact Capital- ZHZen11 Holdings
2b AHEAD Ventures
Graphene Ventures
Mack Financial- SCStarling Locke Capital
Other known investors3 additional known investors
California Life Sciences- DIDellin Investments
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about X-Therma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See X-Therma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.